Aerovate Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Aerovate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aerovate Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aerovate Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $190k | 76k | 2.51 |
| 2024-12-31 | $178k | 67k | 2.65 |
| 2024-09-30 | $13k | 6.0k | 2.09 |
| 2024-06-30 | $9.7k | 5.8k | 1.66 |
| 2024-03-31 | $136k | 4.6k | 29.57 |
| 2023-12-31 | $169k | 7.5k | 22.63 |
| 2023-09-30 | $101k | 7.4k | 13.57 |
| 2023-06-30 | $139k | 8.1k | 17.25 |
| 2023-03-31 | $1.1k | 50 | 21.74 |
| 2022-12-31 | $229k | 5.3k | 43.48 |
| 2022-06-30 | $92k | 5.9k | 15.68 |
| 2022-03-31 | $166k | 9.0k | 18.45 |
| 2021-12-31 | $70k | 6.0k | 11.62 |